APA (7th ed.) Citation

Evans, J. (2024). US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives. Pediatric News, 1.

Chicago Style (17th ed.) Citation

Evans, Jeff. "US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives." Pediatric News 2024: 1.

MLA (9th ed.) Citation

Evans, Jeff. "US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives." Pediatric News, 2024, p. 1.